Tivic Health Systems, Inc. (TIVC) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

and the questions you have submitted in advance will be answered following the prepared remarks. This call is being webcast, and the replay will be available on the IR section of the company's website for three months. Before we begin, let me remind you that during today's call, management will make various forward-looking statements. Investors are questioned that these forward-looking statements are based on current expectations and are subject to risks and uncertainties. That could cause actual results or outcomes to differ materially from those indicated in our forward-looking statements. Please read the safe harbor statement contained in the press release, Terrific Health issued today, as well as the risk factors contained in Terrific Health's filings with the SEC, including its annual report on Form 10-K of the year end December 31, 2024, and the Form 10-Q report to be filed with the SEC today, as well as other companies' SEC filings. On today's call, we have Trivik Health's Chief Executive Officer, Jennifer Earnest, Interim Chief Financial Officer, Lisa Wolf, and Chief Operating Officer and President of Trivik Biopharma, Michael Hanley. Now let me turn the call over to Jennifer Earnest. Thank you to the operator for that introduction, and welcome to both the investors that are listening today and to those that are listening at another time. I'm Jennifer Ernst, CEO of Tivic Health, and it is my absolute pleasure to be here with you today to share some of the perspectives on our first quarter of 2025. There's really no doubt in my mind that this will be one of the defining moments in Tivic's history. In recent months, we have catalyzed an aggressive reinvention of Tivic, It's tempting to point to a single event or a quarter, but really what we're reporting on tod...